Patent directory · USPTO A61K / A61P
Patents matching “Rigel Pharmaceuticals, Inc.”
373 pharma patents match "Rigel Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 373 pharmaceutical patents matching "Rigel Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10947216
Amide compounds and method for making and using
granted -
US 10941134
AMPK-activating heterocyclic compounds and methods for using the same
granted -
US 10941140
IRAK inhibitors and method for making and using
granted -
US 10941135
Nrf2 activating compounds and uses thereof
granted -
US 10889562
Prodrugs of Nrf2 activating compounds and uses thereof
granted -
US 10858335
2,3-Disubstituted pyridine compounds as TGF-β inhibitors and methods of use
granted -
US 10851093
Tyrosine kinase inhibitors
granted -
US 10844040
Nrf2 activating compounds and uses thereof
granted -
US 10828301
2,4-pyrimidinediamine compounds and their uses
granted -
US 10822337
TGF-β inhibitorC
granted -
US 10815206
RIP1 inhibitory compounds and methods for making and using the same
granted -
US 10792282
Protein kinase C inhibitors and uses thereof
granted -
US 10774066
Prodrugs of NRF2 activating compounds and uses thereof
granted -
US 10774076
Benzazole compounds and methods for making and using the compounds
granted -
US 10759855
Antigen binding molecules to TIGIT
granted -
US 10710983
2,4-diamino-pyrimidine compounds and method for making and using the compounds
granted -
US 10709703
2,4-pyrimidinediamine compounds and their uses
granted -
US 10696693
Fused imidazole derivatives as TGF-beta inhibitors
granted -
US 10682350
2,4-pyrimidinediamine compounds and their uses
granted -
US 10647697
Nrf2 activating compounds and uses thereof
granted -
US 10590121
Kinase inhibitors and methods for making and using
granted -
US 10577381
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
granted -
US 10556891
Compositions and methods for inhibition of the JAK pathway
granted -
US 10556881
Nrf2 activating compounds and uses thereof
granted